A class action lawsuit has been filed against ZoomInfo Technologies Inc. and some of its officers for allegedly making false and misleading statements about the company's growth prospects and financial health between November 2025 and May 2026. The suit claims ZoomInfo misrepresented slowing demand, weakening upsell opportunities, and the impact of customers shifting to consumption-based models and internal AI solutions. After ZoomInfo cut its 2026 revenue guidance by $62 million in May, its stock price dropped 33%. Investors who suffered losses can join the lawsuit by August 24, 2026, to seek damages.
The Fédération Internationale de l'Automobile (FIA) reported its best financial performance in 10 years for fiscal 2025, achieving an operating profit of €6.7 million, a 43% increase from the previous year, and reversing a €24 million loss in 2021. R...
Kyivstar, part of VEON Group, signed a Memorandum of Understanding with Ukraine's Ministry of Economy to develop a sovereign AI-ready data center. This initiative aims to enhance Ukraine's digital infrastructure, secure sensitive data within the coun...
The global Laboratory Information Management Systems (LIMS) market is projected to grow from $2.88 billion in 2025 to $5.19 billion by 2030, at a CAGR of 12.5%. Growth is fueled by rising demand for laboratory automation, regulatory compliance, and d...
Peec AI has assembled a team of SEO experts and AI researchers to understand how AI platforms like ChatGPT, Perplexity, and Google's AI Mode select and recommend brands. This team uses reverse-engineering and experimental analysis to decode the opaqu...
Monteverde & Associates PC, a top-ranked class action law firm, is investigating Bio-Techne Corporation's proposed sale to Merck KGaA. Shareholders are expected to receive $73 per share in cash under the deal. The firm encourages Bio-Techne sharehold...
